|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||72.25 - 73.85|
|52 Week Range||64.47 - 79.74|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.10%|
What should investors worried about a trade war do? Mark Haefele, the global chief investment officer for UBS Wealth Management, has offered a game plan focused on stock sectors and regions.
Market timing is generally agreed to be extremely challenging. Yet seasonal factors do persist in the market over time and could offer you a slight edge when buying or selling.
Is one corner of Europe—Portugal—offering a good deal? Yes, say the bulls, as they emphasize that Portugese stocks are benefiting from a greatly improved economic backdrop.
Financial markets across the globe received another jolt from the US president even before they could completely recover from the rise in volatility that was witnessed at the beginning of February. President Donald Trump seems to be working toward his promise to put America first, announcing that he will introduce tariffs of 25% and 10% on imports of steel and aluminum, respectively. President Trump said that US steel (SLX) and aluminum industry players such as Alcoa (AA) and Newmont Mining (NEM) need support to return to their past glory.
Billionaire investor Dan Loeb is known in the market for his event-driven investment strategies. According to CNBC, Loeb wrote, “While we remain optimistic about the trajectory of the economy and markets, we have weighed our positioning with an acute awareness of the risks. On economic growth, Loeb wrote, “Since growth is already at a high level, further acceleration is less likely.
In its 3Q17 earnings conference call, GlaxoSmithKline (GSK) has projected its Vaccines segment revenues to rise annually in the mid to high single digits until 2020. The company has also estimated 30% plus profit margins for its vaccines segment by 2020. A major part of this growth is expected to be attributable to the newly launched Shingrix vaccine as well as rapid uptake of meningitis vaccines Menveo and Bexsero.
GlaxoSmithKline (GSK) is focused on advancing its fixed-dose combination long-acting muscarinic antagonist (or LAMA) and long-acting beta agonist (or LABA) therapy, Anoro Ellipta, and open triple therapy comprising of inhaled corticosteroid (or ICS) and LABA therapy, Revlar/Breo and LAMA therapy, Incruse Ellipta, in the chronic obstructive pulmonary disease (or COPD) segment.
Investing doesn't need to be complicated or expensive. Build a dirt-cheap portfolio that can last a lifetime with just one stock ETF and one bond ETF.
While 2018 is still in its infancy, there are already signs of a prominent theme from 2017 extending into the new year. Year-to-date, four of the top 10 asset-gathering exchange-traded funds (ETFs) are ex-U.S. equity funds.
According to a report by Markit Economics, Russia’s service PMI (purchasing managers’ index) showed a solid improvement in November 2017, rising to 57.4 from 53.9 in October. The figure beat the…
The Japan Services PMI fell in November 2017. It came in at 51.2 compared to 53.4 in October. It didn’t meet the market expectation of 52.0.
Japan’s services PMI (EWJ) (DXJ) rose solidly in October 2017. It stood at 53.4 in October 2017 compared to 51.0 in September 2017.
According to the report provided by Markit Economics, Japan’s services PMI (EWJ) (DXJ) stood at 51.0 in September 2017 compared to 51.6 in August 2017.